After watching this webinar, participants will:
• gain insights into clinical concepts and state-of-the-art anticoagulation measures for stroke prevention;
• understand anticoagulation treatment options with the pros and cons of currently available drugs;
• be aware of the emerging novel category of new anticoagulation treatments (FXI inhibitors); and
• gain knowledge about the application of various anticoagulation treatments in special patient cohorts (subgroups involving high risk or comorbidities).
This programme is supported by Bayer AG in the form of an educational grant.
The scientific programme has not been influenced in any way by its sponsor.